285 related articles for article (PubMed ID: 12726822)
1. Bi-phasic change in BDNF gene expression following antidepressant drug treatment.
Coppell AL; Pei Q; Zetterström TS
Neuropharmacology; 2003 Jun; 44(7):903-10. PubMed ID: 12726822
[TBL] [Abstract][Full Text] [Related]
2. Sequential changes in BDNF mRNA expression and synaptic levels of AMPA receptor subunits in rat hippocampus after chronic antidepressant treatment.
Martínez-Turrillas R; Del Río J; Frechilla D
Neuropharmacology; 2005 Dec; 49(8):1178-88. PubMed ID: 16143352
[TBL] [Abstract][Full Text] [Related]
3. Biphasic change in BDNF gene expression following antidepressant drug treatment explained by differential transcript regulation.
Khundakar AA; Zetterström TSC
Brain Res; 2006 Aug; 1106(1):12-20. PubMed ID: 16842762
[TBL] [Abstract][Full Text] [Related]
4. Differential regulation of central BDNF protein levels by antidepressant and non-antidepressant drug treatments.
Balu DT; Hoshaw BA; Malberg JE; Rosenzweig-Lipson S; Schechter LE; Lucki I
Brain Res; 2008 May; 1211():37-43. PubMed ID: 18433734
[TBL] [Abstract][Full Text] [Related]
5. Antidepressant-induced regulation of 5-HT(1b) mRNA in rat dorsal raphe nucleus reverses rapidly after drug discontinuation.
Anthony JP; Sexton TJ; Neumaier JF
J Neurosci Res; 2000 Jul; 61(1):82-7. PubMed ID: 10861803
[TBL] [Abstract][Full Text] [Related]
6. Effects of antidepressant drugs on synaptic protein levels and dendritic outgrowth in hippocampal neuronal cultures.
Seo MK; Lee CH; Cho HY; Lee JG; Lee BJ; Kim JE; Seol W; Kim YH; Park SW
Neuropharmacology; 2014 Apr; 79():222-33. PubMed ID: 24296153
[TBL] [Abstract][Full Text] [Related]
7. Effects of chronic antidepressant treatments on serotonin transporter function, density, and mRNA level.
Benmansour S; Cecchi M; Morilak DA; Gerhardt GA; Javors MA; Gould GG; Frazer A
J Neurosci; 1999 Dec; 19(23):10494-501. PubMed ID: 10575045
[TBL] [Abstract][Full Text] [Related]
8. Antidepressant drug treatment induces Arc gene expression in the rat brain.
Pei Q; Zetterström TS; Sprakes M; Tordera R; Sharp T
Neuroscience; 2003; 121(4):975-82. PubMed ID: 14580947
[TBL] [Abstract][Full Text] [Related]
9. Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments.
Nibuya M; Morinobu S; Duman RS
J Neurosci; 1995 Nov; 15(11):7539-47. PubMed ID: 7472505
[TBL] [Abstract][Full Text] [Related]
10. Antidepressants that inhibit both serotonin and norepinephrine reuptake impair long-term potentiation in hippocampus.
Cooke JD; Cavender HM; Lima HK; Grover LM
Psychopharmacology (Berl); 2014 Dec; 231(23):4429-41. PubMed ID: 24781518
[TBL] [Abstract][Full Text] [Related]
11. Effects of acute and repeated administration of antidepressant drugs on extracellular levels of 5-hydroxytryptamine measured in vivo.
Kreiss DS; Lucki I
J Pharmacol Exp Ther; 1995 Aug; 274(2):866-76. PubMed ID: 7636750
[TBL] [Abstract][Full Text] [Related]
12. Temporal expression of brain-derived neurotrophic factor (BDNF) mRNA in the rat hippocampus after treatment with selective and mixed monoaminergic antidepressants.
Larsen MH; Hay-Schmidt A; Rønn LC; Mikkelsen JD
Eur J Pharmacol; 2008 Jan; 578(2-3):114-22. PubMed ID: 17950272
[TBL] [Abstract][Full Text] [Related]
13. Chronic treatment with desipramine and fluoxetine modulate BDNF, CaMKKalpha and CaMKKbeta mRNA levels in the hippocampus of transgenic mice expressing antisense RNA against the glucocorticoid receptor.
Vinet J; Carra S; Blom JM; Brunello N; Barden N; Tascedda F
Neuropharmacology; 2004 Dec; 47(7):1062-9. PubMed ID: 15555640
[TBL] [Abstract][Full Text] [Related]
14. Activation and desensitization by cyclic antidepressant drugs of alpha2-autoreceptors, alpha2-heteroreceptors and 5-HT1A-autoreceptors regulating monamine synthesis in the rat brain in vivo.
Esteban S; Lladó J; Sastre-Coll A; García-Sevilla JA
Naunyn Schmiedebergs Arch Pharmacol; 1999 Aug; 360(2):135-43. PubMed ID: 10494882
[TBL] [Abstract][Full Text] [Related]
15. The differential regulation of BDNF and TrkB levels in juvenile rats after four days of escitalopram and desipramine treatment.
Kozisek ME; Middlemas D; Bylund DB
Neuropharmacology; 2008 Feb; 54(2):251-7. PubMed ID: 18048068
[TBL] [Abstract][Full Text] [Related]
16. Subchronic treatment with fluoxetine and ketanserin increases hippocampal brain-derived neurotrophic factor, β-catenin and antidepressant-like effects.
Pilar-Cuéllar F; Vidal R; Pazos A
Br J Pharmacol; 2012 Feb; 165(4b):1046-57. PubMed ID: 21627639
[TBL] [Abstract][Full Text] [Related]
17. Antidepressant-like behavioral effects of IGF-I produced by enhanced serotonin transmission.
Hoshaw BA; Hill TI; Crowley JJ; Malberg JE; Khawaja X; Rosenzweig-Lipson S; Schechter LE; Lucki I
Eur J Pharmacol; 2008 Oct; 594(1-3):109-16. PubMed ID: 18675266
[TBL] [Abstract][Full Text] [Related]
18. Chronic administration of the delta opioid receptor agonist (+)BW373U86 and antidepressants on behavior in the forced swim test and BDNF mRNA expression in rats.
Torregrossa MM; Folk JE; Rice KC; Watson SJ; Woods JH
Psychopharmacology (Berl); 2005 Nov; 183(1):31-40. PubMed ID: 16220339
[TBL] [Abstract][Full Text] [Related]
19. Fluoxetine-induced change in rat brain expression of brain-derived neurotrophic factor varies depending on length of treatment.
De Foubert G; Carney SL; Robinson CS; Destexhe EJ; Tomlinson R; Hicks CA; Murray TK; Gaillard JP; Deville C; Xhenseval V; Thomas CE; O'Neill MJ; Zetterström TS
Neuroscience; 2004; 128(3):597-604. PubMed ID: 15381288
[TBL] [Abstract][Full Text] [Related]
20. The role of 5-hydroxytryptamine receptor subtypes in the regulation of brain-derived neurotrophic factor gene expression.
Zetterström TS; Coppell AA; Khundakar AA
J Pharm Pharmacol; 2014 Jan; 66(1):53-61. PubMed ID: 24341949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
